In temozolomide-resistant glioblastoma stem-like cells, m6A modification significantly increases, and temozolomide treatment induces upregulation of METTL3, leading to increased m6A methylation (Li et al., 2021). The gene discussed is METTL3; the disease is glioblastoma.